Share

March 11, 2014; 82 (10) Editorial

Obesity and HLA in multiple sclerosis

Weighty matters

Ruth Ann Marrie, Christopher A. Beck
First published February 5, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000195
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
190

Share

Article Information

vol. 82 no. 10 826-827
DOI: 
https://doi.org/10.1212/WNL.0000000000000195
PubMed: 
24500648
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published February 5, 2014.

Article Versions

Copyright & Usage: 
© 2014 American Academy of Neurology

Author Disclosures

    1. Ruth Ann Marrie, MD, PhD and
    2. Christopher A. Beck, PhD
  1. Ruth Ann Marrie, MD, PhD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neurology, Editorial Board, Multiple Sclerosis Journal, Editorial Board

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Received support as site Principal Investigator for clinical trials from Sanofi-Aventis (2007-2013)

    Research Support, Government Entities:

    1. Received support as principal investigator from the Canadian Institutes of Health Research (2010-2014), the Public Health Agency of Canada (2010-2014).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Received support as principal investigator from Multiple Sclerosis Society of Canada (2009-2016), and as co-principal investigator from Multiple Sclerosis Scientific Foundation (2009-2014). Received support from Consortium of Multiple Sclerosis Centers (2004-2009, 2011-2013).

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Christopher A. Beck, PhD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. (1) American Academy of Neurology, biostatistical reviewer for Neurology.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Amarin, (2) Guidant Corporation, (3) Boston Scientific Corporation, (4) Auspex Pharmaceuticals

    Research Support, Government Entities:

    1. (1) National Institutes of Health, R01 NS046487-05, Biostatistician, 2004-2010, (2) National Institutes of Health, P50 AR054041, Biostatistician, 2006-2017, (3) National Institutes of Health, R01 NS060022-03, Biostatistician, 2007-2011, (4) National Institutes of Health, R01 NS045686-04, Biostatistician, 2004-2010, (5) National Institutes of Health, R01 ES008442-09S1, Biostatistician, 2009-2010, (6) National Institutes of Health, U01 NS050095-04, Biostatistician, 2004-2009, (7) National Institutes of Health, R21 CA119112-02, Biostatistician, 2007-2009, (8) National Institutes of Health, R01 HD057977-02, Biostatistician, 2009-2014, (9) National Institutes of Health, U01 HL096607, Biostatistician, 2010-2015, (10) FDA, FD003908, Biostatistician, 2011-2015,

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) CHDI Foundation, Inc., (2) National Parkinson Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Internal Medicine and Community Health Sciences (R.A.M.), University of Manitoba, Winnipeg, Canada; and the Department of Biostatistics and Computational Biology (C.A.B.), University of Rochester Medical Center, NY.
  1. Correspondence to Dr. Marrie: rmarrie{at}hsc.mb.ca
View Full Text

Article usage

Article usage: February 2014 to February 2023

AbstractFullPdfSource
Feb 2014190354Highwire
Mar 20143493055Highwire
Apr 2014491616Highwire
May 20143246Highwire
Jun 201483116Highwire
Jul 20143985Highwire
Aug 20141010Highwire
Sep 20141920Highwire
Oct 20143280Highwire
Nov 20142152Highwire
Dec 20141400Highwire
Jan 20152211Highwire
Feb 20152200Highwire
Mar 20152511Highwire
Apr 20151841Highwire
May 20151643Highwire
Jun 20152433Highwire
Jul 20152701Highwire
Aug 20152234Highwire
Sep 20152421Highwire
Oct 20151711Highwire
Nov 20151622Highwire
Dec 20152300Highwire
Jan 20161200Highwire
Feb 20161411Highwire
Mar 20161110Highwire
Apr 2016611Highwire
May 2016611Highwire
Jun 20161200Highwire
Jul 20161131Highwire
Aug 20161100Highwire
Sep 2016711Highwire
Oct 2016810Highwire
Nov 20161613Highwire
Dec 2016300Highwire
Jan 2017300Highwire
Feb 20171100Highwire
Mar 2017400Highwire
Apr 2017500Highwire
May 20171130Highwire
Jun 2017200Highwire
Jul 2017400Highwire
Aug 2017100Highwire
Sep 2017200Highwire
Oct 2017500Highwire
Nov 2017300Highwire
Dec 2017601Highwire
Jan 20182011Highwire
Feb 20181210Highwire
Mar 20181300Highwire
Apr 20181111Highwire
May 20181300Highwire
Jun 20183500Highwire
Jul 20181600Highwire
Aug 20181710Highwire
Sep 20182013Highwire
Oct 2018800Highwire
Nov 20181111Highwire
Dec 20181300Highwire
Jan 2019700Highwire
Feb 20191000Highwire
Mar 20191000Highwire
Apr 2019600Highwire
May 20191411Highwire
Jun 2019800Highwire
Jul 2019411Highwire
Aug 2019301Highwire
Sep 2019200Highwire
Oct 2019900Highwire
Nov 2019911Highwire
Dec 2019310Highwire
Jan 2020720Highwire
Feb 2020500Highwire
Mar 2020900Highwire
Apr 2020841Highwire
May 2020100Highwire
Jun 2020811Highwire
Jul 2020210Highwire
Aug 2020500Highwire
Sep 2020500Highwire
Oct 20201030Highwire
Nov 2020620Highwire
Dec 2020600Highwire
Jan 2021501Highwire
Feb 2021810Highwire
Mar 20211600Highwire
Apr 20211111Highwire
May 2021900Highwire
Jun 20211000Highwire
Jul 2021800Highwire
Aug 20211000Highwire
Sep 2021600Highwire
Oct 2021800Highwire
Nov 20211900Highwire
Dec 2021700Highwire
Jan 2022900Highwire
Feb 20221700Highwire
Mar 2022600Highwire
Apr 20221400Highwire
May 2022700Highwire
Jun 20221001Highwire
Jul 2022501Highwire
Aug 2022400Highwire
Sep 2022900Highwire
Oct 20221211Highwire
Nov 20221100Highwire
Dec 20221000Highwire
Jan 2023711Highwire
Feb 2023511Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles